A new study suggests that elevated ACE2 and TMPRSS2 expression in the nasal cavity significantly increases the risk of future SARS-CoV-2 infection, with certain nasal microbiome species ...

“Thus, the more IL-26 there is in the nasal cavity, the lesser the chronic airflow limitation in these patients,” Lindén and colleagues wrote. In terms of T cells, both CD4+ and CD8+ T cells ...

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Physical variations within the nasal cavity contribute to recurrent bleeding yet often go undetected during standard examinations. Deviated septums represent the most common structural issue ...

The recommended dose of Atzumi is 5.2 mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine ...

You fill the pot with a saline solution, tilt your head over a sink, insert the spout into one nostril, and allow the solution to flow through your nasal cavity and out the other nostril.

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years. The Food and Drug ...

Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...

Please provide your email address to receive an email when new articles are posted on . Nasal spray offers an alternative for patients who are afraid of needles. Participants absorbed epinephrine ...

The University Hospital of Tours, Tours, France, and the ANRS Emerging Infectious Diseases are set to initiate a clinical trial of a nasal spray vaccine against SARS-CoV-2, developed by the start ...